2020 Q4 Form 10-Q Financial Statement
#000119312520285735 Filed on November 05, 2020
Income Statement
| Concept | 2020 Q4 | 2020 Q3 | 2019 Q3 |
|---|---|---|---|
| Revenue | $42.69M | $38.89M | $27.84M |
| YoY Change | 38.78% | 39.66% | 66.63% |
| Cost Of Revenue | $8.100M | $7.261M | $5.349M |
| YoY Change | 32.57% | 35.74% | 93.1% |
| Gross Profit | $34.59M | $31.63M | $22.50M |
| YoY Change | 40.38% | 40.59% | 61.37% |
| Gross Profit Margin | 81.03% | 81.33% | 80.79% |
| Selling, General & Admin | $30.76M | $26.64M | $17.15M |
| YoY Change | 83.1% | 55.35% | -22.43% |
| % of Gross Profit | 88.93% | 84.25% | 76.24% |
| Research & Development | $11.31M | $10.38M | $8.665M |
| YoY Change | 48.43% | 19.8% | -23.18% |
| % of Gross Profit | 32.7% | 32.83% | 38.52% |
| Depreciation & Amortization | $980.0K | -$754.0K | -$512.0K |
| YoY Change | -35.95% | 47.27% | |
| % of Gross Profit | 2.83% | -2.38% | -2.28% |
| Operating Expenses | $42.24M | $37.02M | $25.82M |
| YoY Change | 71.64% | 43.42% | -22.66% |
| Operating Profit | -$7.650M | -$5.399M | -$3.320M |
| YoY Change | -25600.0% | 62.62% | -82.92% |
| Interest Expense | $520.0K | $380.0K | $640.0K |
| YoY Change | -26.76% | -40.63% | 236.84% |
| % of Operating Profit | |||
| Other Income/Expense, Net | $384.0K | $635.0K | |
| YoY Change | -39.53% | ||
| Pretax Income | -$7.510M | -$5.015M | -$2.685M |
| YoY Change | -2782.14% | 86.78% | -86.07% |
| Income Tax | -$3.800M | $300.0K | $429.0K |
| % Of Pretax Income | |||
| Net Earnings | -$3.710M | -$5.265M | -$3.114M |
| YoY Change | 1666.67% | 69.08% | -83.9% |
| Net Earnings / Revenue | -8.69% | -13.54% | -11.18% |
| Basic Earnings Per Share | |||
| Diluted Earnings Per Share | -$40.38K | -$140.5K | -$38.61K |
| COMMON SHARES | |||
| Basic Shares Outstanding | 91.19M | ||
| Diluted Shares Outstanding |
Balance Sheet
| Concept | 2020 Q4 | 2020 Q3 | 2019 Q3 |
|---|---|---|---|
| SHORT-TERM ASSETS | |||
| Cash & Short-Term Investments | $598.1M | $578.0M | |
| YoY Change | |||
| Cash & Equivalents | $164.5M | $324.3M | $80.91M |
| Short-Term Investments | $433.6M | $253.7M | |
| Other Short-Term Assets | $17.50M | $14.10M | |
| YoY Change | |||
| Inventory | |||
| Prepaid Expenses | |||
| Receivables | $37.05M | $25.54M | |
| Other Receivables | $0.00 | $0.00 | |
| Total Short-Term Assets | $652.6M | $617.7M | |
| YoY Change | 228.04% | ||
| LONG-TERM ASSETS | |||
| Property, Plant & Equipment | $4.963M | $4.497M | |
| YoY Change | 40.52% | ||
| Goodwill | $17.32M | $17.32M | |
| YoY Change | 0.0% | ||
| Intangibles | $4.047M | $4.419M | |
| YoY Change | -27.84% | ||
| Long-Term Investments | |||
| YoY Change | |||
| Other Assets | $5.391M | $5.920M | |
| YoY Change | -40.17% | ||
| Total Long-Term Assets | $36.67M | $36.28M | |
| YoY Change | -6.24% | ||
| TOTAL ASSETS | |||
| Total Short-Term Assets | $652.6M | $617.7M | |
| Total Long-Term Assets | $36.67M | $36.28M | |
| Total Assets | $689.2M | $654.0M | |
| YoY Change | 189.54% | ||
| SHORT-TERM LIABILITIES | |||
| YoY Change | |||
| Accounts Payable | $9.911M | $8.849M | |
| YoY Change | 98.62% | ||
| Accrued Expenses | $21.00M | $11.90M | |
| YoY Change | |||
| Deferred Revenue | $91.75M | $78.28M | |
| YoY Change | 26.25% | ||
| Short-Term Debt | $0.00 | $0.00 | |
| YoY Change | |||
| Long-Term Debt Due | |||
| YoY Change | |||
| Total Short-Term Liabilities | $122.7M | $99.12M | |
| YoY Change | 42.67% | ||
| LONG-TERM LIABILITIES | |||
| Long-Term Debt | $0.00 | $0.00 | |
| YoY Change | |||
| Other Long-Term Liabilities | $1.550M | $458.0K | |
| YoY Change | |||
| Total Long-Term Liabilities | $1.550M | $458.0K | |
| YoY Change | |||
| TOTAL LIABILITIES | |||
| Total Short-Term Liabilities | $122.7M | $99.12M | |
| Total Long-Term Liabilities | $1.550M | $458.0K | |
| Total Liabilities | $135.3M | $107.6M | |
| YoY Change | 41.52% | ||
| SHAREHOLDERS EQUITY | |||
| Retained Earnings | -$74.79M | -$71.08M | |
| YoY Change | 14.38% | ||
| Common Stock | $628.3M | $617.1M | |
| YoY Change | 1868.7% | ||
| Preferred Stock | |||
| YoY Change | |||
| Treasury Stock (at cost) | |||
| YoY Change | |||
| Treasury Stock Shares | |||
| Shareholders Equity | $553.9M | $546.4M | -$35.11M |
| YoY Change | |||
| Total Liabilities & Shareholders Equity | $689.2M | $654.0M | |
| YoY Change | 189.54% |
Cashflow Statement
| Concept | 2020 Q4 | 2020 Q3 | 2019 Q3 |
|---|---|---|---|
| OPERATING ACTIVITIES | |||
| Net Income | -$3.710M | -$5.265M | -$3.114M |
| YoY Change | 1666.67% | 69.08% | -83.9% |
| Depreciation, Depletion And Amortization | $980.0K | -$754.0K | -$512.0K |
| YoY Change | -35.95% | 47.27% | |
| Cash From Operating Activities | $12.82M | $10.78M | |
| YoY Change | 33.82% | ||
| INVESTING ACTIVITIES | |||
| Capital Expenditures | -$910.0K | -$1.100M | |
| YoY Change | 28.17% | ||
| Acquisitions | |||
| YoY Change | |||
| Other Investing Activities | -$180.9M | -$110.4M | |
| YoY Change | 287.66% | ||
| Cash From Investing Activities | -$181.8M | -$111.5M | |
| YoY Change | 283.71% | ||
| FINANCING ACTIVITIES | |||
| Cash Dividend Paid | |||
| YoY Change | |||
| Common Stock Issuance & Retirement, Net | |||
| YoY Change | |||
| Debt Paid & Issued, Net | |||
| YoY Change | |||
| Cash From Financing Activities | 9.200M | 398.5M | |
| YoY Change | 6471.43% | ||
| NET CHANGE | |||
| Cash From Operating Activities | 12.82M | 10.78M | |
| Cash From Investing Activities | -181.8M | -111.5M | |
| Cash From Financing Activities | 9.200M | 398.5M | |
| Net Change In Cash | -159.8M | 297.8M | |
| YoY Change | 324.26% | ||
| FREE CASH FLOW | |||
| Cash From Operating Activities | $12.82M | $10.78M | |
| Capital Expenditures | -$910.0K | -$1.100M | |
| Free Cash Flow | $13.73M | $11.88M | |
| YoY Change | 33.43% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2020Q3 | us-gaap |
Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
|
324288000 | |
| CY2019Q4 | us-gaap |
Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
|
39150000 | |
| CY2020Q3 | us-gaap |
Short Term Investments
ShortTermInvestments
|
253748000 | |
| CY2019Q4 | us-gaap |
Short Term Investments
ShortTermInvestments
|
127331000 | |
| CY2020Q3 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
25543000 | |
| CY2019Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
24736000 | |
| CY2020Q3 | us-gaap |
Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
|
2864000 | |
| CY2019Q4 | us-gaap |
Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
|
2348000 | |
| CY2020Q3 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
11249000 | |
| CY2019Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
5364000 | |
| CY2020Q3 | us-gaap |
Assets Current
AssetsCurrent
|
617692000 | |
| CY2019Q4 | us-gaap |
Assets Current
AssetsCurrent
|
198929000 | |
| CY2020Q3 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
4497000 | |
| CY2019Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
3532000 | |
| CY2020Q3 | us-gaap |
Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
|
4119000 | |
| CY2019Q4 | us-gaap |
Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
|
3641000 | |
| CY2020Q3 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
4419000 | |
| CY2019Q4 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
5608000 | |
| CY2020Q3 | us-gaap |
Goodwill
Goodwill
|
17320000 | |
| CY2019Q4 | us-gaap |
Goodwill
Goodwill
|
17320000 | |
| CY2020Q3 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
5920000 | |
| CY2019Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
9010000 | |
| CY2020Q3 | us-gaap |
Assets
Assets
|
653967000 | |
| CY2019Q4 | us-gaap |
Assets
Assets
|
238040000 | |
| CY2020Q3 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
8849000 | |
| CY2019Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
4990000 | |
| CY2020Q3 | us-gaap |
Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
|
11988000 | |
| CY2019Q4 | us-gaap |
Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
|
8335000 | |
| CY2020Q3 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
78280000 | |
| CY2019Q4 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
72676000 | |
| CY2020Q3 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
99117000 | |
| CY2019Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
86001000 | |
| CY2020Q3 | us-gaap |
Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
|
8014000 | |
| CY2019Q4 | us-gaap |
Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
|
9629000 | |
| CY2020Q3 | us-gaap |
Liabilities
Liabilities
|
107589000 | |
| CY2019Q4 | us-gaap |
Liabilities
Liabilities
|
95630000 | |
| CY2020Q3 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
||
| CY2019Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
||
| CY2020Q3 | us-gaap |
Common Stock Value
CommonStockValue
|
254000 | |
| CY2019Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
80000 | |
| CY2020Q3 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
616860000 | |
| CY2019Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
31835000 | |
| CY2020Q3 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
339000 | |
| CY2019Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
35000 | |
| CY2020Q3 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-71075000 | |
| CY2019Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-65384000 | |
| CY2020Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
546378000 | |
| CY2019Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-33434000 | |
| CY2020Q3 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
653967000 | |
| CY2019Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
238040000 | |
| CY2020Q3 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
| CY2019Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
| CY2020Q3 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.01 | |
| CY2020Q3 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.01 | |
| CY2020Q3 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
50000000 | |
| CY2019Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
0 | |
| CY2020Q3 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | |
| CY2019Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | |
| CY2020Q3 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | |
| CY2019Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | |
| CY2019Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.01 | |
| CY2019Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.01 | |
| CY2020Q3 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
500000000 | |
| CY2019Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
101314353 | |
| CY2019Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
27930741 | |
| CY2019Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
27930741 | |
| CY2020Q3 | us-gaap |
Conversion Of Stock Shares Converted1
ConversionOfStockSharesConverted1
|
52063647 | |
| CY2020Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
|
138400 | |
| CY2020Q3 | us-gaap |
Deferred Offering Costs
DeferredOfferingCosts
|
5400000 | |
| CY2019Q4 | us-gaap |
Deferred Offering Costs
DeferredOfferingCosts
|
500000 | |
| CY2019Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
40943000 | |
| us-gaap |
Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
|
-1012000 | ||
| CY2018Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
179788000 | |
| CY2020Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
324556000 | |
| CY2019Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
82982000 | |
| us-gaap |
Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
|
<div style="text-indent: 4%; font-family: 'times new roman'; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; background: none;"><div style="font-family: 'times new roman'; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Reclassifications </div></div></div></div><div style="text-indent: 4%; font-family: 'times new roman'; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; background: none;"><div style="font-family: 'times new roman'; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Certain prior period amounts have been reclassified in order to conform to the current period presentation. </div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | ||
| us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="text-indent: 4%; font-family: 'times new roman'; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; background: none;"><div style="font-family: 'times new roman'; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Use of Estimates </div></div></div></div><div style="text-indent: 4%; font-family: 'times new roman'; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; background: none;"><div style="font-family: 'times new roman'; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting periods and accompanying notes. Significant items subject to such estimates and assumptions include, but are not limited to, the allocation of transaction price among various performance obligations, the estimated customer life on deferred contract acquisition costs, the allowance for doubtful accounts, the fair value of financial assets and liabilities; including accounting and fair value of derivatives, the fair value of acquired intangible assets and goodwill, the useful lives of acquired intangible assets and property and equipment, share-based compensation including the determination of the fair value of the Company’s share-based awards, and the valuation of deferred tax assets and uncertain tax positions. The Company bases these estimates on historical and anticipated results, trends and various other assumptions that it believes are reasonable under the circumstances, including assumptions as to future events. Actual results could differ from those estimates. </div></div><div style="text-indent: 4%; font-family: 'times new roman'; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; background: none;">The novel coronavirus <div style="white-space: nowrap; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">(“COVID-19”)</div> pandemic has created, and may continue to create, significant uncertainty in macroeconomic conditions, and the extent of its impact on the Company’s operational and financial performance will depend on certain developments, including the duration and spread of the outbreak and the impact on the Company’s customers and its sales cycles, as discussed in more detail in the section titled “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Recent Developments”. The Company considered the impact of <div style="white-space: nowrap; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> on the estimates and assumptions and determined that there were no material adverse impacts on the condensed consolidated financial statements for the period ended September 30, 2020. As events continue to evolve and additional information becomes available, the Company’s estimates and assumptions may change materially in future periods.</div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | ||
| us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<div style="text-indent: 4%; font-family: 'times new roman'; font-size: 10pt; margin-top: 16pt; margin-bottom: 0pt; background: none;"><div style="display:inline;"><div style="background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: 'times new roman'; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Concentration of Risks </div></div></div></div></div></div> <div style="font-family: 'times new roman'; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;"> </div></div></div><div style="text-indent: 4%; font-family: 'times new roman'; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; background: none;"><div style="font-family: 'times new roman'; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Financial instruments that potentially subject the Company to a concentration of credit risk consist of cash and cash equivalents, restricted cash, short-term investments, accounts receivable, and derivative instruments. The Company maintains its cash, cash equivalents, restricted cash, and short-term investments with high-quality financial institutions mainly in the U.S. and Israel, the composition and maturities of which are regularly monitored by the Company. The Company grants credit to its customers in the normal course of business. </div></div><div style="text-indent: 4%; font-family: 'times new roman'; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; background: none;"><div style="font-family: 'times new roman'; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">As of September 30, 2020 and December 31, 2019, no single customer represented 10% or more of accounts receivable. No single customer accounted for more than 10% of total revenue for the periods presented. </div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | ||
| CY2020Q3 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
7261000 | |
| CY2019Q3 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
5349000 | |
| us-gaap |
Cost Of Revenue
CostOfRevenue
|
20354000 | ||
| us-gaap |
Cost Of Revenue
CostOfRevenue
|
13922000 | ||
| us-gaap |
Net Income Loss
NetIncomeLoss
|
-5691000 | ||
| us-gaap |
Net Income Loss
NetIncomeLoss
|
-5183000 | ||
| us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
2683000 | ||
| us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
2043000 | ||
| us-gaap |
Share Based Compensation
ShareBasedCompensation
|
14399000 | ||
| us-gaap |
Share Based Compensation
ShareBasedCompensation
|
7541000 | ||
| us-gaap |
Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
|
367000 | ||
| us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
807000 | ||
| us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-313000 | ||
| us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
4285000 | ||
| us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
5281000 | ||
| us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
2273000 | ||
| us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
1306000 | ||
| us-gaap |
Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
|
4063000 | ||
| us-gaap |
Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
|
831000 | ||
| us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
3989000 | ||
| us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
5942000 | ||
| us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
16642000 | ||
| us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
5399000 | ||
| us-gaap |
Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
|
235773000 | ||
| us-gaap |
Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
|
132526000 | ||
| us-gaap |
Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
|
105823000 | ||
| us-gaap |
Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
|
22295000 | ||
| us-gaap |
Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
|
2598000 | ||
| us-gaap |
Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
|
29160000 | ||
| us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
2611000 | ||
| us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
1383000 | ||
| us-gaap |
Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
|
20860000 | ||
| us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-129963000 | ||
| us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-103314000 | ||
| us-gaap |
Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
|
395211000 | ||
| us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
1723000 | ||
| us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
1109000 | ||
| us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
396934000 | ||
| us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
1109000 | ||
| us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
283613000 | ||
| us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-96806000 | ||
| CY2020Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-5399000 | |
| CY2019Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-3320000 | |
| us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-6160000 | ||
| CY2020Q3 | us-gaap |
Gross Profit
GrossProfit
|
31625000 | |
| CY2019Q3 | us-gaap |
Gross Profit
GrossProfit
|
22495000 | |
| us-gaap |
Gross Profit
GrossProfit
|
87784000 | ||
| us-gaap |
Gross Profit
GrossProfit
|
60037000 | ||
| CY2020Q3 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
10381000 | |
| CY2019Q3 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
8665000 | |
| us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
29452000 | ||
| us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
21764000 | ||
| CY2020Q3 | us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
14839000 | |
| CY2019Q3 | us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
12042000 | |
| us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
42744000 | ||
| us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
31784000 | ||
| CY2020Q3 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
11804000 | |
| CY2019Q3 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
5108000 | |
| us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
21748000 | ||
| us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
12991000 | ||
| CY2020Q3 | us-gaap |
Operating Expenses
OperatingExpenses
|
37024000 | |
| CY2019Q3 | us-gaap |
Operating Expenses
OperatingExpenses
|
25815000 | |
| us-gaap |
Operating Expenses
OperatingExpenses
|
93944000 | ||
| us-gaap |
Operating Expenses
OperatingExpenses
|
66539000 | ||
| us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-6502000 | ||
| CY2020Q3 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
384000 | |
| CY2019Q3 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
635000 | |
| us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
1522000 | ||
| us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
2457000 | ||
| CY2020Q3 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-5015000 | |
| CY2019Q3 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-2685000 | |
| us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-4638000 | ||
| us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-4045000 | ||
| CY2020Q3 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
250000 | |
| CY2019Q3 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
429000 | |
| us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
1053000 | ||
| us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
1138000 | ||
| CY2020Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-5265000 | |
| CY2019Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-3114000 | |
| CY2020Q3 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.14 | |
| CY2019Q3 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.11 | |
| us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.18 | ||
| us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.19 | ||
| CY2020Q3 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
37515828 | |
| CY2019Q3 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
27462776 | |
| us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
31359164 | ||
| us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
26879292 | ||
| CY2020Q3 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
-218000 | |
| CY2019Q3 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
-16000 | |
| us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
77000 | ||
| us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
85000 | ||
| CY2020Q3 | us-gaap |
Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
|
-232000 | |
| us-gaap |
Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
|
227000 | ||
| CY2020Q3 | us-gaap |
Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
|
450000 | |
| CY2019Q3 | us-gaap |
Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
|
16000 | |
| us-gaap |
Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
|
-304000 | ||
| us-gaap |
Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
|
-85000 | ||
| CY2020Q3 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-5715000 | |
| CY2019Q3 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-3130000 | |
| us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-5387000 | ||
| us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-5098000 | ||
| CY2020Q3 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
38886000 | |
| CY2019Q3 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
27844000 | |
| us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
108138000 | ||
| us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
73959000 | ||
| CY2019Q4 | us-gaap |
Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
|
127296000 | |
| CY2019Q4 | us-gaap |
Available For Sale Securities
AvailableForSaleSecurities
|
127331000 | |
| CY2020Q3 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
91136070 | |
| CY2020Q3 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
91136070 | |
| CY2020Q3 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
8270000 | |
| CY2019Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
6438000 | |
| CY2020Q3 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
3773000 | |
| CY2019Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
2906000 | |
| CY2020Q3 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
7506000 | |
| CY2019Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
5333000 | |
| CY2020Q3 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
4482000 | |
| CY2019Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
3002000 | |
| CY2020Q3 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
11988000 | |
| CY2019Q4 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
8335000 | |
| CY2019Q4 | us-gaap |
Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
|
1.00 | |
| CY2020Q1 | us-gaap |
Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
|
0.50 | |
| CY2019Q4 | us-gaap |
Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
|
0.03 | |
| CY2020Q1 | us-gaap |
Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
|
0.06 | |
| CY2020Q3 | us-gaap |
Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
|
200000 | |
| CY2019Q3 | us-gaap |
Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
|
100000 | |
| us-gaap |
Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
|
600000 | ||
| us-gaap |
Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
|
400000 | ||
| CY2020Q3 | us-gaap |
Deferred Policy Acquisition Costs Additions
DeferredPolicyAcquisitionCostsAdditions
|
1303000 | |
| CY2019Q3 | us-gaap |
Deferred Policy Acquisition Costs Additions
DeferredPolicyAcquisitionCostsAdditions
|
984000 | |
| us-gaap |
Deferred Policy Acquisition Costs Additions
DeferredPolicyAcquisitionCostsAdditions
|
3088000 | ||
| us-gaap |
Deferred Policy Acquisition Costs Additions
DeferredPolicyAcquisitionCostsAdditions
|
3008000 | ||
| CY2020Q3 | us-gaap |
Deferred Policy Acquisition Cost Amortization Expense
DeferredPolicyAcquisitionCostAmortizationExpense
|
-754000 | |
| CY2019Q3 | us-gaap |
Deferred Policy Acquisition Cost Amortization Expense
DeferredPolicyAcquisitionCostAmortizationExpense
|
-512000 | |
| us-gaap |
Deferred Policy Acquisition Cost Amortization Expense
DeferredPolicyAcquisitionCostAmortizationExpense
|
-2094000 | ||
| us-gaap |
Deferred Policy Acquisition Cost Amortization Expense
DeferredPolicyAcquisitionCostAmortizationExpense
|
-1261000 | ||
| us-gaap |
Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
|
632000 | ||
| us-gaap |
Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
|
328000 | ||
| us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
304000 | ||
| us-gaap |
Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
|
88000 | ||
| us-gaap |
Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
|
3000 | ||
| us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
85000 | ||
| CY2019Q3 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
85000 | |
| CY2020Q3 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
7642000 | |
| CY2020Q3 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
-3223000 | |
| CY2020Q3 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
4419000 | |
| CY2019Q4 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
7642000 | |
| CY2019Q4 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
-2034000 | |
| CY2019Q4 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
5608000 | |
| CY2020Q3 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
400000 | |
| CY2019Q3 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
400000 | |
| us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
1200000 | ||
| us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
1100000 | ||
| CY2020Q3 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
|
373000 | |
| CY2020Q3 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
|
1382000 | |
| CY2020Q3 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
|
961000 | |
| CY2020Q3 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
|
886000 | |
| CY2020Q3 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
|
667000 | |
| CY2020Q3 | us-gaap |
Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
|
150000 | |
| CY2020Q3 | us-gaap |
Derivative Notional Amount
DerivativeNotionalAmount
|
16343000 | |
| CY2019Q4 | us-gaap |
Derivative Notional Amount
DerivativeNotionalAmount
|
9672000 | |
| dei |
Document Type
DocumentType
|
10-Q | ||
| dei |
Amendment Flag
AmendmentFlag
|
false | ||
| dei |
Document Period End Date
DocumentPeriodEndDate
|
2020-09-30 | ||
| dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2020 | ||
| dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q3 | ||
| dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001800667 | ||
| dei |
Document Quarterly Report
DocumentQuarterlyReport
|
true | ||
| dei |
Document Transition Report
DocumentTransitionReport
|
false | ||
| dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | ||
| dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | ||
| dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | ||
| dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
No | ||
| CY2020Q2 | us-gaap |
Deferred Policy Acquisition Costs
DeferredPolicyAcquisitionCosts
|
6434000 | |
| CY2019Q2 | us-gaap |
Deferred Policy Acquisition Costs
DeferredPolicyAcquisitionCosts
|
4865000 | |
| CY2019Q4 | us-gaap |
Deferred Policy Acquisition Costs
DeferredPolicyAcquisitionCosts
|
5989000 | |
| CY2018Q4 | us-gaap |
Deferred Policy Acquisition Costs
DeferredPolicyAcquisitionCosts
|
3590000 | |
| CY2020Q3 | us-gaap |
Deferred Policy Acquisition Costs
DeferredPolicyAcquisitionCosts
|
6983000 | |
| CY2019Q3 | us-gaap |
Deferred Policy Acquisition Costs
DeferredPolicyAcquisitionCosts
|
5337000 | |
| CY2020Q3 | us-gaap |
Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
|
1157000 | |
| CY2020Q3 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
|
4854000 | |
| CY2020Q3 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
|
3492000 | |
| CY2020Q3 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
|
2016000 | |
| CY2020Q3 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
|
1889000 | |
| CY2020Q3 | us-gaap |
Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
|
1497000 | |
| CY2020Q3 | us-gaap |
Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
|
14905000 | |
| dei |
Entity Shell Company
EntityShellCompany
|
false | ||
| dei |
Entity Small Business
EntitySmallBusiness
|
false | ||
| dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
true | ||
| dei |
Entity Ex Transition Period
EntityExTransitionPeriod
|
false | ||
| dei |
Trading Symbol
TradingSymbol
|
FROG | ||
| dei |
Security12b Title
Security12bTitle
|
Ordinary Shares, NIS 0.01 par value | ||
| dei |
Security Exchange Name
SecurityExchangeName
|
NASDAQ | ||
| CY2020Q3 | us-gaap |
Operating Lease Expense
OperatingLeaseExpense
|
900000 | |
| CY2019Q3 | us-gaap |
Operating Lease Expense
OperatingLeaseExpense
|
700000 | |
| us-gaap |
Operating Lease Expense
OperatingLeaseExpense
|
3000000 | ||
| us-gaap |
Operating Lease Expense
OperatingLeaseExpense
|
2300000 | ||
| dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
L3 | ||
| CY2020Q3 | us-gaap |
Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
|
15700000 | |
| CY2019Q3 | us-gaap |
Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
|
12000000 | |
| us-gaap |
Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
|
64100000 | ||
| us-gaap |
Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
|
45400000 | ||
| CY2020Q3 | us-gaap |
Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
|
91200000 | |
| CY2020Q3 | us-gaap |
Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
|
0.88 | |
| CY2020Q3 | us-gaap |
Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
|
27084589 | |
| CY2019Q4 | us-gaap |
Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
|
66693184 | |
| CY2019Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
|
1119471 | |
| CY2019Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
13201986 | |
| CY2019Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
2.71 | |
| CY2019 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P6Y10M24D | |
| CY2019Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
163876000 | |
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
|
2908755 | ||
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
2908755 | ||
| CY2020Q3 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
393233000 | |
| CY2020Q3 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
817000 | |
| CY2020Q3 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
9660000 | |
| CY2020Q3 | us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
-450000 | |
| us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
20.13 | ||
| us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
1115535 | ||
| us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
1.55 | ||
| frog |
Sharebased Compensation Arrangement By Sharebased Payment Award Shares Cancelled
SharebasedCompensationArrangementBySharebasedPaymentAwardSharesCancelled
|
821105 | ||
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
821105 | ||
| us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
|
5.65 | ||
| CY2020Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
|
10131821 | |
| CY2020Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
14174101 | |
| CY2020Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
6.20 | |
| us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P7Y | ||
| CY2020Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
1111897000 | |
| CY2020Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
6339551 | |
| CY2020Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
1.25 | |
| us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
|
P5Y | ||
| CY2020Q3 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
|
528701000 | |
| CY2020Q3 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
9660000 | |
| CY2019Q3 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
4895000 | |
| us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
14399000 | ||
| us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
7541000 | ||
| CY2020Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-27461000 | |
| CY2020Q3 | us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
175844000 | |
| CY2019Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-37390000 | |
| CY2019Q3 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
511000 | |
| CY2019Q3 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
4895000 | |
| CY2019Q3 | us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
-16000 | |
| CY2019Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-35114000 | |
| us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
175844000 | ||
| us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
393233000 | ||
| us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
1723000 | ||
| us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
304000 | ||
| CY2018Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-38677000 | |
| us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
1109000 | ||
| us-gaap |
Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
|
11000 | ||
| us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
7541000 | ||
| us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
85000 | ||
| CY2019Q4 | us-gaap |
Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
|
175844000 | |
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
|
11100000 | ||
| us-gaap |
Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
|
0 | ||
| CY2020Q3 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
59308732 | |
| CY2019Q3 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
65320911 | |
| us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
63516144 | ||
| us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
65536483 | ||
| dei |
Entity Registrant Name
EntityRegistrantName
|
JFrog Ltd | ||
| CY2020Q3 | us-gaap |
Purchase Obligation Future Minimum Payments Remainder Of Fiscal Year
PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear
|
636000 | |
| CY2020Q3 | us-gaap |
Purchase Obligation Due In Second Year
PurchaseObligationDueInSecondYear
|
7079000 | |
| CY2020Q3 | us-gaap |
Purchase Obligation Due In Third Year
PurchaseObligationDueInThirdYear
|
3141000 | |
| CY2020Q3 | us-gaap |
Purchase Obligation
PurchaseObligation
|
10856000 | |
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
|
33074000 | ||
| frog |
Increase Decrease In Capitalized Contract Cost
IncreaseDecreaseInCapitalizedContractCost
|
994000 | ||
| frog |
Increase Decrease In Capitalized Contract Cost
IncreaseDecreaseInCapitalizedContractCost
|
1746000 | ||
| dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
CA | ||
| CY2020Q4 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
91193180 | |
| CY2020Q3 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
458000 | |
| CY2020Q3 | us-gaap |
Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
|
||
| CY2020Q3 | us-gaap |
Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
|
||
| us-gaap |
Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
|
|||
| us-gaap |
Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
|
|||
| CY2020Q3 | us-gaap |
Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
|
253636000 | |
| CY2020Q3 | us-gaap |
Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
|
148000 | |
| CY2020Q3 | us-gaap |
Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
|
36000 | |
| CY2020Q3 | us-gaap |
Available For Sale Securities
AvailableForSaleSecurities
|
253748000 | |
| CY2020Q3 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
900000 | |
| CY2020Q3 | us-gaap |
Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
|
500000 | |
| CY2020Q3 | us-gaap |
Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
|
2100000 | |
| CY2019Q4 | us-gaap |
Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
|
55000 | |
| CY2019Q4 | us-gaap |
Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
|
20000 | |
| us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
14399000 | ||
| CY2020Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
324288000 | |
| CY2019Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
80909000 | |
| CY2020Q3 | us-gaap |
Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
|
14000 | |
| CY2019Q3 | us-gaap |
Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
|
221000 | |
| CY2020Q3 | us-gaap |
Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
|
254000 | |
| CY2019Q3 | us-gaap |
Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
|
1852000 | |
| CY2019Q3 | us-gaap |
Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
|
2072000 | |
| CY2019Q3 | us-gaap |
Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
|
3265000 | |
| CY2020Q3 | us-gaap |
Capitalized Contract Cost Net
CapitalizedContractCostNet
|
6983000 | |
| CY2019Q3 | us-gaap |
Capitalized Contract Cost Net
CapitalizedContractCostNet
|
5337000 |
